Xie Yuanfen, Li Chunqin, Dong Xige, Wang Beilei, Qin Jiaxin, Lv Huanhuan
School of Life Sciences, Northwestern Polytechnical University, Xi'an 710072, China.
Key Laboratory for Space Bioscience and Biotechnology, Northwestern Polytechnical University, Xi'an 710072, China.
Nutrients. 2025 Aug 21;17(16):2714. doi: 10.3390/nu17162714.
Diabetes, a major global healthcare challenge, is characterized by chronic hyperglycemia and significantly exacerbates the severity of systemic complications. Iron, an essential element ubiquitously present in biological systems, is involved in many biological processes facilitating cell proliferation and growth. However, excessive iron accumulation promotes oxidative damage through the Fenton reaction, thereby increasing the incidence of diabetes and worsening diabetic complications. Notably, ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as a key mechanism underlying diabetes and diabetic complications. In this review, we provide an update on the current understanding of iron metabolism dysregulation in diabetes risk, and disclose the mechanistic links between iron overload and diabetes evidenced in hereditary hemochromatosis and thalassemia. We particularly highlight iron-mediated oxidative stress as a central nexus impairing glucose metabolism and insulin sensitivity. Furthermore, we discuss the significance of dysmetabolic iron and ferroptosis activation in the progression of diabetes and diabetic complications, as well as the possible application of natural products for iron metabolism regulation and ferroptosis-inhibition-targeted therapeutic strategies to treat diabetes and diabetic complications.
糖尿病是一项重大的全球医疗挑战,其特征为慢性高血糖,并显著加剧全身并发症的严重程度。铁是生物系统中普遍存在的一种必需元素,参与许多促进细胞增殖和生长的生物过程。然而,过量的铁积累通过芬顿反应促进氧化损伤,从而增加糖尿病的发病率并加重糖尿病并发症。值得注意的是,铁死亡是一种由脂质过氧化驱动的铁依赖性调节性细胞死亡形式,已成为糖尿病及糖尿病并发症的关键潜在机制。在本综述中,我们提供了关于目前对糖尿病风险中铁代谢失调的理解的最新情况,并揭示了遗传性血色素沉着症和地中海贫血中所证实的铁过载与糖尿病之间的机制联系。我们特别强调铁介导的氧化应激是损害葡萄糖代谢和胰岛素敏感性的核心环节。此外,我们讨论了代谢紊乱的铁和铁死亡激活在糖尿病及糖尿病并发症进展中的意义,以及天然产物在调节铁代谢和靶向抑制铁死亡治疗策略以治疗糖尿病及糖尿病并发症方面的可能应用。